Académique Documents
Professionnel Documents
Culture Documents
Bianca Tester
September 18, 2018
To me, the slight difference in the dose to the lungs, stomach, etc. didn’t give me enough reason
to want to accept such a high spinal cord dose (since the dose with the conformal plan is still
well below the accepted tolerances). The QUANTEC3 max dose for the spinal cord is 45 Gy,
and the SupaFireFly technique gave the spinal cord a max dose of 41.2 Gy while my conformal
arc plan only gave 26.9 Gy. Knowing that esophageal cancer is very difficult to treat, and has a
high likelihood to recur, I don’t feel comfortable giving that much dose to the spinal cord when
the patient might need to come back for more radiation. If this patient specifically had heart or
lung problems then I would be more inclined to use Matt Palmer’s plan.
3
Below is an example of a side-by-side comparison between Matt’s plan (shown on the left) and
mine (on the right). As you can see from the isodose lines in the transverse image, although
Matt’s plan has less of the 1008 cGy overall, he has an isodose line of 3528 cGy dosing the
spinal cord, versus mine being missed even by the 2520 cGy isodose line.
Shown below is a coronal view, again, with Matt’s plan on the left and mine on the right. Matt’s
plan is slightly more conformal and his plan does have slightly better PTV coverage as well,
however the comparisons were so close I felt the spinal cord dose was the deciding factor for me.
4
References
1. Yang G, McClosky S, Khushalani N. Principles of modern radiation techniques for
esophageal and gastroesophageal junction cancer. Gastrointest Cancer Res. 2009 Mar-
Apr; 3(2 Suppl 1): S6-S10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2684733/
2. Palmer, M. Advancement in treatment planning techniques and technologies for
esophagus cancer. [PowerPoint lecture]. MD Anderson cancer center. La Crosse, WI:
UW-L Medical Dosimetry Program; 2017.
3. Bentzen S, Constine L, Deasy J, et al. Quantitative analyses of normal tissue effects in
the clinic (QUANTEC): An introduction to the scientific issues. Int J Radiat Oncol Biol
Phys. 2010 Mar 1; 76(3 Suppl): S3-S9. doi: 10.1016/j.ijrobp.2009.09.040.